RxDoctor Payments Data

Jason Huffman, MD

Orthopaedic Surgery of the Spine · Napa, CANPI 1144240003

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (48.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Spineart SA at 42.6% of the total. 2025 is the largest year on record at $61,035, 2.4 times the $25,134 reported in 2019.

$298,269in general payments, 2019–2025

Across 277 payments — averaging $1076.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineart SA$127K
  • Spineart USA Inc$83K
  • Integrity Implants Inc.$40K
  • Spineology Inc.$27K
  • Spine Wave, Inc.$15K
  • Integrity Implants Inc. Dba Accelus$2K
  • plus $4K from 18 others
$86,723in research payments, 2019–2025

Across 9 payments — averaging $9635.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spineology Inc.$84K
  • GS Solutions, Inc.$3K

What the payments were for

  • Royalty or licence$144,57548%
  • Consulting fees$59,97720%
  • Speaking & faculty fees$18,0006%
  • Travel & lodging$61,65421%
  • Food & beverage$13,9795%
  • Education$400%
  • Gifts$440%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$298,269 in reported general payments places this provider in the 80th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$1,246,568
Medicare patients
760
Services billed
8,389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib56$1,845
Lidocaine21$1,678
Gabapentin110$1,496
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen85$980
Cyclobenzaprine Hcl13$330
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen17$329
Pregabalin12$260
Methocarbamol26$236
Diclofenac Sodium21$125
Methylprednisolone18$106
Oxycodone Hcl14$105
Tramadol Hcl14$84
Ibuprofen12$50
Meloxicam12$42
Diazepam12$17

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Napa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →